142 related articles for article (PubMed ID: 30974322)
1. Prognostic nutritional index as a prognostic marker in glioblastoma: Data from a cohort of 282 Italian patients.
Rigamonti A; Imbesi F; Silvani A; Lamperti E; Agostoni E; Porcu L; De Simone I; Torri V; Ciusani E; Bonato C; Salmaggi A
J Neurol Sci; 2019 May; 400():175-179. PubMed ID: 30974322
[TBL] [Abstract][Full Text] [Related]
2. Antiepileptic treatment and survival in newly diagnosed glioblastoma patients: Retrospective multicentre study in 285 Italian patients.
Rigamonti A; Imbesi F; Silvani A; Gaviani P; Agostoni E; Porcu L; De Simone I; Torri V; Salmaggi A
J Neurol Sci; 2018 Jul; 390():14-19. PubMed ID: 29801876
[TBL] [Abstract][Full Text] [Related]
3. Significance of the prognostic nutritional index in patients with glioblastoma: A retrospective study.
Zhou XW; Dong H; Yang Y; Luo JW; Wang X; Liu YH; Mao Q
Clin Neurol Neurosurg; 2016 Dec; 151():86-91. PubMed ID: 27816892
[TBL] [Abstract][Full Text] [Related]
4. Role of multidimensional assessment of frailty in predicting outcomes in older patients with glioblastoma treated with adjuvant concurrent chemo-radiation.
Giaccherini L; Galaverni M; Renna I; Timon G; Galeandro M; Pisanello A; Russo M; Botti A; Iotti C; Ciammella P
J Geriatr Oncol; 2019 Sep; 10(5):770-778. PubMed ID: 31005645
[TBL] [Abstract][Full Text] [Related]
5. Comparison of neutrophil to lymphocyte ratio and prognostic nutritional index with other clinical and molecular biomarkers for prediction of glioblastoma multiforme outcome.
Garrett C; Becker TM; Lynch D; Po J; Xuan W; Scott KF; de Souza P
PLoS One; 2021; 16(6):e0252614. PubMed ID: 34138894
[TBL] [Abstract][Full Text] [Related]
6. Is age an additional factor in the treatment of elderly patients with glioblastoma? A new stratification model: an Italian Multicenter Study.
Ius T; Somma T; Altieri R; Angileri FF; Barbagallo GM; Cappabianca P; Certo F; Cofano F; D'Elia A; Della Pepa GM; Esposito V; Fontanella MM; Germanò A; Garbossa D; Isola M; La Rocca G; Maiuri F; Olivi A; Panciani PP; Pignotti F; Skrap M; Spena G; Sabatino G
Neurosurg Focus; 2020 Oct; 49(4):E13. PubMed ID: 33002864
[TBL] [Abstract][Full Text] [Related]
7. Pre-operative hematological markers as predictive factors for overall survival and progression free survival in glioblastomas.
Marini A; Dobran M; Aiudi D; Pesaresi A; di Somma LGM; Iacoangeli M
Clin Neurol Neurosurg; 2020 Oct; 197():106162. PubMed ID: 32890893
[TBL] [Abstract][Full Text] [Related]
8. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
9. The Prognostic Value of the Pretreatment Neutrophil/Lymphocyte Ratio in Patients with Glioblastoma Multiforme Brain Tumors: A Retrospective Cohort Study of Patients Treated with Combined Modality Surgery, Radiation Therapy, and Temozolomide Chemotherapy.
Brenner A; Friger M; Geffen DB; Kaisman-Elbaz T; Lavrenkov K
Oncology; 2019; 97(5):255-263. PubMed ID: 31288238
[TBL] [Abstract][Full Text] [Related]
10. Age-adjusted Charlson comorbidity index in recurrent glioblastoma: a new prognostic factor?
Barz M; Bette S; Janssen I; Aftahy AK; Huber T; Liesche-Starnecker F; Ryang YM; Wiestler B; Combs SE; Meyer B; Gempt J
BMC Neurol; 2022 Jan; 22(1):32. PubMed ID: 35062885
[TBL] [Abstract][Full Text] [Related]
11. A Cumulative Score Based on Preoperative Neutrophil-Lymphocyte Ratio and Fibrinogen in Predicting Overall Survival of Patients with Glioblastoma Multiforme.
Hao Y; Li X; Chen H; Huo H; Liu Z; Tian F; Chai E
World Neurosurg; 2019 Aug; 128():e427-e433. PubMed ID: 31042598
[TBL] [Abstract][Full Text] [Related]
12. The Prognostic Impact of Nutritional Status on Postoperative Outcomes in Glioblastoma.
Huq S; Khalafallah AM; Botros D; Oliveira LAP; White T; Dux H; Jimenez AE; Mukherjee D
World Neurosurg; 2021 Feb; 146():e865-e875. PubMed ID: 33197633
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of the postoperative prognostic nutritional index in patients with glioblastoma: a retrospective study.
Kim YJ; Oh H; Lee SJ; Kim KM; Kang H; Park CK; Park HP
BMC Cancer; 2021 Aug; 21(1):942. PubMed ID: 34418999
[TBL] [Abstract][Full Text] [Related]
14. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
Li YM; Suki D; Hess K; Sawaya R
J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
[TBL] [Abstract][Full Text] [Related]
15. Impact of prognostic nutritional index on survival in recurrent glioblastoma.
Alan O; Telli TA; Basoğlu T; Arikan R; Demircan NC; Ercelep O; Sakar M; Bozkurt S; Atasoy BM; Dane F; Ziyal Mİ; Yumuk PF
Neurocirugia (Astur : Engl Ed); 2022; 33(1):15-21. PubMed ID: 34998488
[TBL] [Abstract][Full Text] [Related]
16. Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme.
Seidlitz A; Siepmann T; Löck S; Juratli T; Baumann M; Krause M
Radiat Oncol; 2015 Aug; 10():172. PubMed ID: 26276734
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of the Glasgow Prognostic Score for glioblastoma multiforme patients treated with radiotherapy and temozolomide.
Topkan E; Selek U; Ozdemir Y; Yildirim BA; Guler OC; Ciner F; Mertsoylu H; Tufan K
J Neurooncol; 2018 Sep; 139(2):411-419. PubMed ID: 29696530
[TBL] [Abstract][Full Text] [Related]
18. Multicentre prospective collection of newly diagnosed glioblastoma patients: update on the Lombardia experience.
Salmaggi A; Silvani A; Merli R; Caroli M; Tomei G; Russo A; Riva M; Marchioni E; Imbesi F
Neurol Sci; 2008 Apr; 29(2):77-83. PubMed ID: 18483704
[TBL] [Abstract][Full Text] [Related]
19. Giant cell glioblastoma: a glioblastoma subtype with distinct epidemiology and superior prognosis.
Kozak KR; Moody JS
Neuro Oncol; 2009 Dec; 11(6):833-41. PubMed ID: 19332771
[TBL] [Abstract][Full Text] [Related]
20. Impact of removed tumor volume and location on patient outcome in glioblastoma.
Awad AW; Karsy M; Sanai N; Spetzler R; Zhang Y; Xu Y; Mahan MA
J Neurooncol; 2017 Oct; 135(1):161-171. PubMed ID: 28685405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
